These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 12213068)
1. Anti-AIDS agents 49. Synthesis, anti-HIV, and anti-fusion activities of IC9564 analogues based on betulinic acid. Sun IC; Chen CH; Kashiwada Y; Wu JH; Wang HK; Lee KH J Med Chem; 2002 Sep; 45(19):4271-5. PubMed ID: 12213068 [TBL] [Abstract][Full Text] [Related]
2. Betulinic acid derivatives that target gp120 and inhibit multiple genetic subtypes of human immunodeficiency virus type 1. Lai W; Huang L; Ho P; Li Z; Montefiori D; Chen CH Antimicrob Agents Chemother; 2008 Jan; 52(1):128-36. PubMed ID: 17954689 [TBL] [Abstract][Full Text] [Related]
3. Synthesis and anti-HIV activity of bi-functional betulinic acid derivatives. Huang L; Ho P; Lee KH; Chen CH Bioorg Med Chem; 2006 Apr; 14(7):2279-89. PubMed ID: 16314103 [TBL] [Abstract][Full Text] [Related]
4. Role of human immunodeficiency virus (HIV) type 1 envelope in the anti-HIV activity of the betulinic acid derivative IC9564. Holz-Smith SL; Sun IC; Jin L; Matthews TJ; Lee KH; Chen CH Antimicrob Agents Chemother; 2001 Jan; 45(1):60-6. PubMed ID: 11120945 [TBL] [Abstract][Full Text] [Related]
5. Bifunctional anti-human immunodeficiency virus type 1 small molecules with two novel mechanisms of action. Huang L; Yuan X; Aiken C; Chen CH Antimicrob Agents Chemother; 2004 Feb; 48(2):663-5. PubMed ID: 14742233 [TBL] [Abstract][Full Text] [Related]
7. Anti-AIDS agents. 78. Design, synthesis, metabolic stability assessment, and antiviral evaluation of novel betulinic acid derivatives as potent anti-human immunodeficiency virus (HIV) agents. Qian K; Yu D; Chen CH; Huang L; Morris-Natschke SL; Nitz TJ; Salzwedel K; Reddick M; Allaway GP; Lee KH J Med Chem; 2009 May; 52(10):3248-58. PubMed ID: 19388685 [TBL] [Abstract][Full Text] [Related]
8. Betulinic acid derivatives as human immunodeficiency virus type 2 (HIV-2) inhibitors. Dang Z; Lai W; Qian K; Ho P; Lee KH; Chen CH; Huang L J Med Chem; 2009 Dec; 52(23):7887-91. PubMed ID: 19526990 [TBL] [Abstract][Full Text] [Related]
9. Structure and Anti-HIV Activity of Betulinic Acid Analogues. Huang QX; Chen HF; Luo XR; Zhang YX; Yao X; Zheng X Curr Med Sci; 2018 Jun; 38(3):387-397. PubMed ID: 30074203 [TBL] [Abstract][Full Text] [Related]
10. Anti-AIDS agents 81. Design, synthesis, and structure-activity relationship study of betulinic acid and moronic acid derivatives as potent HIV maturation inhibitors. Qian K; Kuo RY; Chen CH; Huang L; Morris-Natschke SL; Lee KH J Med Chem; 2010 Apr; 53(8):3133-41. PubMed ID: 20329730 [TBL] [Abstract][Full Text] [Related]
11. Anti-AIDS agents--XXVII. Synthesis and anti-HIV activity of betulinic acid and dihydrobetulinic acid derivatives. Hashimoto F; Kashiwada Y; Cosentino LM; Chen CH; Garrett PE; Lee KH Bioorg Med Chem; 1997 Dec; 5(12):2133-43. PubMed ID: 9459011 [TBL] [Abstract][Full Text] [Related]
12. Fluorinated betulinic acid derivatives and evaluation of their anti-HIV activity. Li J; Goto M; Yang X; Morris-Natschke SL; Huang L; Chen CH; Lee KH Bioorg Med Chem Lett; 2016 Jan; 26(1):68-71. PubMed ID: 26598461 [TBL] [Abstract][Full Text] [Related]
13. Synthesis of betulinic acid derivatives as entry inhibitors against HIV-1 and bevirimat-resistant HIV-1 variants. Dang Z; Qian K; Ho P; Zhu L; Lee KH; Huang L; Chen CH Bioorg Med Chem Lett; 2012 Aug; 22(16):5190-4. PubMed ID: 22818973 [TBL] [Abstract][Full Text] [Related]
15. Betulinic acid and its derivatives: a review on their biological properties. Yogeeswari P; Sriram D Curr Med Chem; 2005; 12(6):657-66. PubMed ID: 15790304 [TBL] [Abstract][Full Text] [Related]
16. The design, synthesis and structure-activity relationships associated with C28 amine-based betulinic acid derivatives as inhibitors of HIV-1 maturation. Chen Y; Sit SY; Chen J; Swidorski JJ; Liu Z; Sin N; Venables BL; Parker DD; Nowicka-Sans B; Lin Z; Li Z; Terry BJ; Protack T; Rahematpura S; Hanumegowda U; Jenkins S; Krystal M; Dicker ID; Meanwell NA; Regueiro-Ren A Bioorg Med Chem Lett; 2018 May; 28(9):1550-1557. PubMed ID: 29631960 [TBL] [Abstract][Full Text] [Related]
17. Chemistry, biological activity, and chemotherapeutic potential of betulinic acid for the prevention and treatment of cancer and HIV infection. Cichewicz RH; Kouzi SA Med Res Rev; 2004 Jan; 24(1):90-114. PubMed ID: 14595673 [TBL] [Abstract][Full Text] [Related]
18. [Advances in the study of structural modifications and biological activities of betulinic acids]. Lan P; Zhang DM; Chen WM; Ye WC Yao Xue Xue Bao; 2010 Nov; 45(11):1339-45. PubMed ID: 21361032 [TBL] [Abstract][Full Text] [Related]
19. Design, synthesis, and bio-evaluation of novel triterpenoid derivatives as anti-HIV-1 compounds. Takeuchi R; Ogihara K; Fujimoto J; Sato K; Mase N; Yoshimura K; Harada S; Narumi T Bioorg Med Chem Lett; 2022 Aug; 69():128768. PubMed ID: 35513221 [TBL] [Abstract][Full Text] [Related]
20. Understanding the structure-activity relationship of betulinic acid derivatives as anti-HIV-1 agents by using 3D-QSAR and docking. Lan P; Chen WN; Huang ZJ; Sun PH; Chen WM J Mol Model; 2011 Jul; 17(7):1643-59. PubMed ID: 20978914 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]